Malta - anglès - Medicines Authority

sandoz pharmaceuticals d.d. verovškova ulica 57, si-1000 ljubljana, slovenia - film-coated tablet - deferasirox 90 mg - all other therapeutic products

Malta - anglès - Medicines Authority

sandoz pharmaceuticals d.d. verovškova ulica 57, si-1000 ljubljana, slovenia - film-coated tablet - deferasirox 180 mg - all other therapeutic products

Malta - anglès - Medicines Authority

sandoz pharmaceuticals d.d. verovškova ulica 57, si-1000 ljubljana, slovenia - film-coated tablet - deferasirox 360 mg - all other therapeutic products

Malta - anglès - Medicines Authority

sandoz pharmaceuticals d.d. verovškova ulica 57, si-1000 ljubljana, slovenia - concentrate for solution for infusion - pemetrexed 25 mg/ml - antineoplastic agents

Malta - anglès - Medicines Authority

sandoz pharmaceuticals d.d. verovškova ulica 57, si-1000 ljubljana, slovenia - concentrate for solution for infusion - pemetrexed 25 mg/ml - antineoplastic agents

Malta - anglès - Medicines Authority

sandoz pharmaceuticals d.d. verovškova ulica 57, si-1000 ljubljana, slovenia - concentrate for solution for infusion - pemetrexed 25 mg/ml - antineoplastic agents

Nova Zelanda - anglès - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - piperacillin monohydrate 4.198 g equivalent to piperacillin sodium 4.2531g and 4.0g piperacillin;  ;  ; tazobactam 0.5 g equivalent to tazobactam sodium 0.54733 g - powder for injection - 4 g/0.5 g - active: piperacillin monohydrate 4.198 g equivalent to piperacillin sodium 4.2531g and 4.0g piperacillin     tazobactam 0.5 g equivalent to tazobactam sodium 0.54733 g - indicated for the treatment of the following systemic and/or local bacterial infections in which susceptible organisms have been detected or are suspected: 1. lower respiratory tract infections 2. urinary tract infections (complicated and uncomplicated) 3. intra-abdominal infections 4. skin and skin structure infections 5. bacterial septicaemia 6. gynaecological infections 7. bacterial infections in neutropenic patients. full therapeutic doses of piptaz sandoz plus an aminoglycoside should be used. 8. bone and joint infections 9. polymicrobic infections: piptaz sandoz is indicated for polymicrobic infections including those where aerobic and anaerobic organisms are suspected (intra-abdominal, skin and skin structure, upper and lower respiratory tract, gynaecological). children under the age of 12 years in hospitalised children aged 2 to 12 years, piptaz sandoz is indicated for the treatment of serious intra-abdominal infections. it has not been evaluated in this indication for paediatric patients below the age of 2 years.

Canadà - anglès - Health Canada

sandoz canada incorporated - diclofenac sodium - tablet (extended-release) - 75mg - diclofenac sodium 75mg - other nonsteroidal antiimflammatory agents

Canadà - anglès - Health Canada

sandoz canada incorporated - diclofenac sodium - suppository - 50mg - diclofenac sodium 50mg - other nonsteroidal antiimflammatory agents

Canadà - anglès - Health Canada

sandoz canada incorporated - diclofenac sodium - tablet (extended-release) - 100mg - diclofenac sodium 100mg - other nonsteroidal antiimflammatory agents